Logo image of MGN.OL

MAGNORA ASA (MGN.OL) Stock Fundamental Analysis

OSL:MGN - NO0010187032 - Common Stock

22.65 NOK
+0.25 (+1.12%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MGN. MGN was compared to 20 industry peers in the Independent Power and Renewable Electricity Producers industry. MGN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MGN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MGN had positive earnings in the past year.
MGN had a negative operating cash flow in the past year.
MGN had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MGN reported negative operating cash flow in multiple years.
MGN.OL Yearly Net Income VS EBIT VS OCF VS FCFMGN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 116.80%, MGN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
MGN's Return On Equity of 149.15% is amongst the best of the industry. MGN outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 116.8%
ROE 149.15%
ROIC N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
MGN.OL Yearly ROA, ROE, ROICMGN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

The Profit Margin of MGN (25808.70%) is better than 100.00% of its industry peers.
MGN's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for MGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 25808.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
MGN.OL Yearly Profit, Operating, Gross MarginsMGN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

8

2. Health

2.1 Basic Checks

MGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MGN has less shares outstanding
MGN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MGN has a worse debt to assets ratio.
MGN.OL Yearly Shares OutstandingMGN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MGN.OL Yearly Total Debt VS Total AssetsMGN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 8.30 indicates that MGN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.30, MGN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
MGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.3
ROIC/WACCN/A
WACC8.52%
MGN.OL Yearly LT Debt VS Equity VS FCFMGN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.24 indicates that MGN has no problem at all paying its short term obligations.
The Current ratio of MGN (2.24) is better than 85.00% of its industry peers.
MGN has a Quick Ratio of 2.24. This indicates that MGN is financially healthy and has no problem in meeting its short term obligations.
MGN's Quick ratio of 2.24 is amongst the best of the industry. MGN outperforms 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
MGN.OL Yearly Current Assets VS Current LiabilitesMGN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 822.27% over the past year.
MGN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 87.45% yearly.
MGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -80.99%.
Measured over the past years, MGN shows a very negative growth in Revenue. The Revenue has been decreasing by -43.96% on average per year.
EPS 1Y (TTM)822.27%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%-132.01%
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%-85.41%

3.2 Future

Based on estimates for the next years, MGN will show a decrease in Earnings Per Share. The EPS will decrease by -2.03% on average per year.
The Revenue is expected to decrease by -0.81% on average over the next years.
EPS Next Y-18.81%
EPS Next 2Y-7.62%
EPS Next 3Y-2.03%
EPS Next 5YN/A
Revenue Next Year-8.07%
Revenue Next 2Y1.5%
Revenue Next 3Y-0.81%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MGN.OL Yearly Revenue VS EstimatesMGN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MGN.OL Yearly EPS VS EstimatesMGN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

MGN is valuated cheaply with a Price/Earnings ratio of 6.26.
Compared to the rest of the industry, the Price/Earnings ratio of MGN indicates a rather cheap valuation: MGN is cheaper than 95.00% of the companies listed in the same industry.
MGN is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 6.34, the valuation of MGN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MGN indicates a rather cheap valuation: MGN is cheaper than 100.00% of the companies listed in the same industry.
MGN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.54.
Industry RankSector Rank
PE 6.26
Fwd PE 6.34
MGN.OL Price Earnings VS Forward Price EarningsMGN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGN.OL Per share dataMGN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

MGN's earnings are expected to decrease with -2.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y-7.62%
EPS Next 3Y-2.03%

0

5. Dividend

5.1 Amount

MGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAGNORA ASA

OSL:MGN (9/10/2025, 7:00:00 PM)

22.65

+0.25 (+1.12%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)07-18 2025-07-18/bmo
Earnings (Next)10-24 2025-10-24
Inst Owners13.43%
Inst Owner ChangeN/A
Ins Owners5.81%
Ins Owner ChangeN/A
Market Cap1.49B
Analysts86.67
Price Target38.08 (68.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.62
Dividend Growth(5Y)0.46%
DP52.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)548.61%
Min EPS beat(2)-312.69%
Max EPS beat(2)1409.9%
EPS beat(4)2
Avg EPS beat(4)263.35%
Min EPS beat(4)-312.69%
Max EPS beat(4)1409.9%
EPS beat(8)2
Avg EPS beat(8)48.92%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)23.14%
Min Revenue beat(2)-72.69%
Max Revenue beat(2)118.97%
Revenue beat(4)3
Avg Revenue beat(4)26.68%
Min Revenue beat(4)-72.69%
Max Revenue beat(4)118.97%
Revenue beat(8)5
Avg Revenue beat(8)21.5%
Revenue beat(12)7
Avg Revenue beat(12)172.33%
Revenue beat(16)9
Avg Revenue beat(16)218.72%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1186.96%
EPS NY rev (1m)3.54%
EPS NY rev (3m)3.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)502.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.26
Fwd PE 6.34
P/S 647.79
P/FCF N/A
P/OCF N/A
P/B 3.74
P/tB 6.08
EV/EBITDA N/A
EPS(TTM)3.62
EY15.98%
EPS(NY)3.57
Fwd EY15.77%
FCF(TTM)-1.57
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS0.03
BVpS6.05
TBVpS3.73
PEG (NY)N/A
PEG (5Y)0.07
Profitability
Industry RankSector Rank
ROA 116.8%
ROE 149.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25808.7%
GM N/A
FCFM N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 8.3
F-Score4
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)19.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)822.27%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%-132.01%
EPS Next Y-18.81%
EPS Next 2Y-7.62%
EPS Next 3Y-2.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%-85.41%
Revenue Next Year-8.07%
Revenue Next 2Y1.5%
Revenue Next 3Y-0.81%
Revenue Next 5YN/A
EBIT growth 1Y75.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.61%
EBIT Next 3Y-6.29%
EBIT Next 5YN/A
FCF growth 1Y-392.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-862.62%
OCF growth 3YN/A
OCF growth 5YN/A